With lot of patient’s dropout from the trials, it is important that we have intelligent and efficient ways to connect back with these patients periodically and provide the information they need. Investments in remote monitoring solutions will be the key to effectively engage patients and provide data they need to make them stay in control.

With new trends, pharma companies will be continuously using remote monitoring solutions for better tracking, delivering and administering of medicines, that allows tracking of patient vital signs and send them remotely to trial sites.

Next generation of patient engagements

With the evolution of Direct to Patient model, pharma companies will lead by bringing more collaborative approaches with provider network to deliver and administer drug therapies directly to patient in the comfort of their homes. What this means can be patient need not go to offline retail channels and instead place orders at the end of the tele health sessions conducted.

These tele health orders can potentially be integrated like electronic prescribing of prescription drugs popularly called as “Rx orders” and can be placed directly to pharma companies order processing units. All you need is a valid Rx and the ability to process these tele health orders which will be further integrated with the insurance companies for the reimbursement flow to complete.

AI/ML Innovations to boost across different areas of Pharma Business: 

AI/ML Driven Digital Health Innovations will impact clinical decision making helping healthcare and pharma companies to fast track clinical screening and drug discovery.

Next Generation of Digital Health Innovation powered by “AI and Data Processing Units (DPU)” is bringing innovations faster than we would imagine.

Adios